UroGen's Chief Medical Officer Sold $400,000 in Stock After a 191% Run

UroGen Pharma’s CMO sold 10,000 shares at $40.00 each, generating about $400,000 in proceeds per the Form 4. The transaction is modest in size and typically has limited immediate impact, but it may be viewed as a mild cautionary signal by the market.

Analysis

UroGen Pharma’s CMO sold 10,000 shares at $40.00 each, generating about $400,000 in proceeds per the Form 4. The transaction is modest in size and typically has limited immediate impact, but it may be viewed as a mild cautionary signal by the market.